DiaMedica Therapeutics Inc. DMAC

Set alert

Price alert · DMAC

All alert types
9.29 USD +0.04 +0.43%

At close · Nov 2

9.29 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
9.30 × 2
Ask
9.31 × 2
8.96 Day range 9.51
5.33 52-week range 9.82
YTD
+16.71%
1 year
+31.59%
Open
9.33
Prev close
9.25
Mkt cap
500.97M
Vol
141.54K
Avg vol
185.28K
EPS
-0.72
P/E
0.00
Div yield
0.00%
More statistics
Low
8.96
High
9.51
Forward P/E
-7.26
Beta
1.46
Short ratio
3.88
Inst. own
31.61%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
4.69
200-d avg
3.61
1y target
7.00

5Y chart

Chart tools
Interval

Events in this range
  • Mar 19, 2024Earnings: -0.14; estimate -0.14; surprise 0%
  • Mar 21, 2024Rating: Oppenheimer · Outperform → Outperform
  • Mar 21, 2024Rating: Craig-Hallum · Buy → Buy
  • May 8, 2024Earnings: -0.14; estimate -0.16; surprise 12.5%
  • May 8, 2024Earnings: —; estimate -0.16; surprise —%
  • Aug 7, 2024Earnings: -0.13; estimate -0.16; surprise 18.75%
  • Aug 7, 2024Earnings: —; estimate -0.16; surprise —%
  • Aug 16, 2024Rating: Oppenheimer · Outperform → Outperform
  • Oct 7, 2024Rating: HC Wainwright & Co. · — → Buy
  • Oct 10, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 13, 2024Earnings: -0.15; estimate -0.15; surprise 0%
  • Nov 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (99)
NameDateAgo
SMA: BullishSep 14, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 7, 20261 month ago
SMA: BullishAug 31, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BearishJul 27, 20263 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Buy SignalJun 29, 20264 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishMar 9, 20267 months ago
SMA: BearishFeb 23, 20268 months ago
SMA: BullishFeb 9, 20268 months ago
SMA: BearishJan 26, 20269 months ago
SMA: BullishJan 19, 20269 months ago
SMA: BearishJan 12, 20269 months ago
MACD: Sell SignalJan 12, 20269 months ago
RSI: OverboughtDec 8, 202511 months ago
SMA: BullishNov 17, 202511 months ago

Newest 20 of 99.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 7.00 -24.7% downside
Target (low)
6.00
Target (mean)
7.00
Target (high)
8.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DMAC analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.1725-0.18 – -0.16-0.14-23.2%00.0%4
Next quarter-0.20-0.21 – -0.19-0.14-42.9%00.0%2
Current year-0.5925-0.60 – -0.58-0.60+1.3%00.0%4
Next year-0.79-0.89 – -0.68-0.5925-33.3%00.0%4

Upgrades and downgrades

The latest rating changes

DMAC analyst upgrades and downgrades
DateFirmActionFromTo
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 7, 2024HC Wainwright & Co.Initiated—Buy
Aug 16, 2024OppenheimerReiteratedOutperformOutperform
Mar 21, 2024Craig-HallumMaintainedBuyBuy
Mar 21, 2024OppenheimerReiteratedOutperformOutperform
Jun 22, 2023OppenheimerUpgradePerformOutperform
Jul 7, 2022Lake StreetMaintained—Buy
Jul 7, 2022Craig-HallumMaintained—Buy
Jul 7, 2022OppenheimerDowngradeOutperformPerform
Jun 30, 2021Roth CapitalMaintained—Buy
Apr 8, 2021OppenheimerInitiated—Outperform
Feb 17, 2021Roth CapitalInitiated—Buy
Jul 8, 2020Maxim GroupInitiated—Buy
May 15, 2020Craig-HallumMaintained—Buy